Search research articles
Contact Us
Filters
Showing results (1061-1070 of 1,277) with videos related to
Page
of 128
Sort By:
Cell Transplantation
|
August 21, 2016
ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design
Tarun Chakravarty, Raj R Makkar, Deborah D Ascheim, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
April 21, 2020
Management of acute myocardial infarction during the COVID-19 pandemic: A Consensus Statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP)
Ehtisham Mahmud, Harold L Dauerman, Frederick G P Welt, et al.
Biorxiv : the Preprint Server for Biology
|
February 3, 2025
PI3K regulates TAZ/YAP and mTORC1 axes that can be synergistically targeted
Keith C Garcia, Ali A Khan, Krishnendu Ghosh, et al.
Journal of the American Heart Association
|
January 1, 2019
Improving Care of STEMI in the United States 2008 to 2012
Christopher B Granger, Eric R Bates, James G Jollis, et al.
Circulation
|
September 20, 2017
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
Sean van Diepen, Jason N Katz, Nancy M Albert, et al.
American Heart Journal
|
April 25, 2007
Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease
Paul Michael Grossman, Farrell Mendelsohn, Timothy D Henry, et al.
Journal of the American College of Cardiology
|
April 30, 2016
Long-Term Post-Discharge Risks in Older Survivors of Myocardial Infarction With and Without Out-of-Hospital Cardiac Arrest
Christopher B Fordyce, Tracy Y Wang, Anita Y Chen, et al.
European Journal of Heart Failure
|
June 1, 2017
Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) study
John R Teerlink, Marco Metra, Gerasimos S Filippatos, et al.
JACC. Cardiovascular Interventions
|
May 26, 2009
Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry
Ali E Denktas, Haris Athar, Timothy D Henry, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
May 20, 2019
SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019
David A Baran, Cindy L Grines, Steven Bailey, et al.
Page
of 128
Search research articles
Search
Showing results (1061-1070 of 1,277) with videos related to
Sort By:
Page
of 128
Cell Transplantation
|
August 21, 2016
ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design
Tarun Chakravarty, Raj R Makkar, Deborah D Ascheim, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
April 21, 2020
Management of acute myocardial infarction during the COVID-19 pandemic: A Consensus Statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP)
Ehtisham Mahmud, Harold L Dauerman, Frederick G P Welt, et al.
Biorxiv : the Preprint Server for Biology
|
February 3, 2025
PI3K regulates TAZ/YAP and mTORC1 axes that can be synergistically targeted
Keith C Garcia, Ali A Khan, Krishnendu Ghosh, et al.
Journal of the American Heart Association
|
January 1, 2019
Improving Care of STEMI in the United States 2008 to 2012
Christopher B Granger, Eric R Bates, James G Jollis, et al.
Circulation
|
September 20, 2017
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
Sean van Diepen, Jason N Katz, Nancy M Albert, et al.
American Heart Journal
|
April 25, 2007
Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease
Paul Michael Grossman, Farrell Mendelsohn, Timothy D Henry, et al.
Journal of the American College of Cardiology
|
April 30, 2016
Long-Term Post-Discharge Risks in Older Survivors of Myocardial Infarction With and Without Out-of-Hospital Cardiac Arrest
Christopher B Fordyce, Tracy Y Wang, Anita Y Chen, et al.
European Journal of Heart Failure
|
June 1, 2017
Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) study
John R Teerlink, Marco Metra, Gerasimos S Filippatos, et al.
JACC. Cardiovascular Interventions
|
May 26, 2009
Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry
Ali E Denktas, Haris Athar, Timothy D Henry, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
May 20, 2019
SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019
David A Baran, Cindy L Grines, Steven Bailey, et al.
Page
of 128